Clinical Trial Update: The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of intravitreal Conbercept for polypoidal choroidal vasculopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Polypoidal Choroidal Vasculopathy (PCV) | Phase 4 | Status: UNKNOWN